Author

M. N. Huang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:variant calling· 3 Assay:whole-genome sequencing· 3 Research Focus:variant effect prediction· 2 Research Focus:GWAS / association mapping· 1 Organism:mouse· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Boot· 3 shared A. W. T. Ng· 2 shared B. T. Teh· 2 shared S. G. Rozen· 2 shared A. Heguy· 1 shared A. Jusakul· 1 shared A. Ng· 1 shared B. Abedi-Ardekani· 1 shared

Activity by Year

2017-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Boot

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivJul 3, 2019

The Repertoire of Mutational Signatures in Human Cancer

L. Alexandrov, J. Kim, N. J. Haradhvala…·M. R. Stratton

The paper characterizes 49 mutational signatures in human cancer using a large dataset of somatic mutations, revealing associations with exposures and DNA repair mechanisms and identifying signatures of unknown origin.

DOI 10.1038/s41586-020-1943-3

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivDec 17, 2017

In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors

A. Boot, M. N. Huang, A. W. T. Ng…·S. G. Rozen

This study identifies the mutational signature of cisplatin in human cell lines and tumors, enabling detection of cisplatin exposure in hepatocellular and esophageal cancers.

DOI 10.1101/gr.230219.117

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivApr 26, 2017

Genome-Scale Mutational Signatures Of Aflatoxin In Cells, Mice And Human Tumors

M. N. Huang, W. Yu, W. W. Teoh…·S. Rozen

This study identifies AFB1 mutational signatures across multiple systems and shows their prevalence in HCCs from different regions, highlighting aflatoxin's public health impact.

DOI 10.1101/gr.220038.116

humanmouse

𝕏 PostBluesky